CRIZALK 250 mg (Crizotinib)


Active Ingredient



Non-small cell lung cancer


Pfizer India Ltd


60 capsules in 1 bottle


250 mg

Delivery Time

6 To 15 days

  • 20% Off Coupan Code GD20
  • Data Privacy and Security
  • Free Shipping on Orders Over $199
Variation Price Quantity Add To Cart
60 Capsule/s $1,850.00
Add to cart
120 Capsule/s $3,550.00
Add to cart
180 Capsule/s $5,199.00
Add to cart

CRIZALK 250 mg is primarily used to treat a specific type of lung cancer called non-small cell lung cancer (NSCLC). CRIZALK 250 mg (Crizotinib) works by blocking certain enzymes involved in the growth and spread of cancer cells. By doing this, Crizotinib can help slow down the progression of the cancer and help improve the quality of life for those affected by the disease.


There are no reviews yet.

Be the first to review “CRIZALK 250 mg (Crizotinib)”

Your email address will not be published. Required fields are marked *